12th Annual Medical Device Strategic Pricing & Accounts Conference

Over the past decade, medical device manufacturers, patients, health systems and other stakeholders have seen a shift in the way devices are being purchased, paid for and reimbursed, all to support the value-based care movement. As health systems look to integrate delivery networks and group purchasing organizations to ensure comprehensive pricing models, manufacturers must consider the impact a product will have on a longer care cycle for patients. With the added shift of the pandemic, other considerations surrounding virtual contracting etiquette, the rise of outpatient centers, and creative avenues to abide by compliance standards are at front of mind.